Infinium Pharmachem Ltd.
Search Company
  You can view the Income statement for the last 5 years.
ISIN No INE0MRE01011 52Wk High (Rs.) 337 BV (Rs.) 81.31 FV (Rs.) 10.00
Bookclosure 13/09/2023 52Wk Low (Rs.) 202 EPS (Rs.) 5.85 P/E (X) 37.08
Mkt Cap. (Rs. Cr.) 301.98 P/BV (X) 2.67 Div Yield (%) 0.00 Mkt Lot 500
 
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)5.827.9718.0054.1326.75
Diluted EPS (Rs.)5.827.9718.0054.1326.75
Cash EPS (Rs.)7.359.7020.5459.8633.15
Book Value[Excl.RevalReserv]/Share (Rs.)67.8441.5042.69123.4569.31
Book Value[Incl.RevalReserv]/Share (Rs.)67.8441.5042.69123.4569.31
Revenue From Operations / Share (Rs.)87.8687.92199.30728.29536.67
PBDIT / Share (Rs.)11.0913.6932.5694.8754.43
PBIT / Share (Rs.)9.1811.9530.0289.1548.03
PBT / Share (Rs.)7.4510.6824.1372.8436.97
Net Profit / Share (Rs.)5.437.9718.0054.1326.75
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)12.6215.5616.3313.0210.14
PBIT Margin (%)10.4413.5915.0612.248.94
PBT Margin (%)8.4712.1412.1010.006.88
Net Profit Margin (%)6.189.069.037.434.98
Return on Networth / Equity (%)8.0119.2042.1643.8538.59
Return on Capital Employeed (%)12.9626.3352.0334.6238.02
Return On Assets (%)5.0914.2615.1411.218.82
Long Term Debt / Equity (X)0.000.090.000.000.00
Total Debt / Equity (X)0.000.090.000.000.00
Asset Turnover Ratio (%)1.121.771.851.852.12
      
LIQUIDITY RATIOS     
      
Current Ratio (X)2.304.131.421.481.24
Quick Ratio (X)1.672.590.830.860.75
Inventory Turnover Ratio (X)4.754.854.454.745.45
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)6.4110.735.525.824.92
Interest Coverage Ratio (Post Tax) (%)4.147.254.054.323.42
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)343.67315.860.000.000.00
EV / Net Operating Revenue (X)2.512.580.000.000.00
EV / EBITDA (X)19.8816.580.000.000.00
MarketCap / Net Operating Revenue (X)2.752.600.000.000.00
Price / BV (X)3.575.520.000.000.00
Price / Net Operating Revenue (X)2.752.600.000.000.00
EarningsYield0.020.030.000.000.00